marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-01-2024
Travere Therapeutics Cash Flow 2011-2024 | TVTX
Annual Cash Flow Travere Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-280 M | -186 M | -14.8 M | -42.7 M | -58.2 M | -25 M | 7.4 M | -3.44 M | -1.39 M | - | -17.6 M | -2.74 M | -689 |
Depreciation & Amortization |
38.5 M | 20.7 M | 12.7 M | 24.6 M | 20.4 M | 18.7 M | 17.8 M | 16.1 M | 13.4 M | 5.4 M | 216 K | 125 K | - |
Accounts Payables |
41.7 M | 17.3 M | 15.1 M | 12.1 M | 26.6 M | 6.95 M | 18.9 M | 7.52 M | 7.64 M | 7.12 M | 3.55 M | 1.02 M | 340 K |
Accounts Receivables |
21.2 M | 16.6 M | 15.9 M | 15.9 M | 18 M | 14.5 M | 13.9 M | 18.5 M | 12.5 M | 7.96 M | - | - | - |
Total Inventories |
9.41 M | 4.52 M | 7.31 M | 7.61 M | 6.08 M | 5.62 M | 5.35 M | 2.83 M | 2.54 M | 801 K | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Travere Therapeutics
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | -119 M | - | - | - | -81.1 M | - | -132 M | - | -55.3 M | - | 12.1 M | - | -26.5 M | - | -28.9 M | -35.6 M | -29.2 M | - | -53.7 M | -39.6 M | -20.5 M | - | -21.4 M | -17.5 M | -14.7 M | - | 8.26 M | 2.06 M | - | - | - | - | - | - | - | - | - | - | - | - | -9.81 M | - | - | -6.79 M | -4.58 M | - | -2.09 M | -1.62 M | -1.22 M | - | -67 | -49 | - |
Depreciation & Amortization |
9.9 M | 9.88 M | - | 10.9 M | 10.4 M | 6.62 M | - | 5.08 M | 7.57 M | 7.09 M | - | 20.6 M | 6.14 M | 6.07 M | - | 17.9 M | 11.5 M | 5.66 M | - | 15.1 M | 9.74 M | 4.9 M | - | 13.8 M | 8.99 M | 4.35 M | - | 13.3 M | 8.72 M | 4.28 M | - | 12 M | 7.86 M | 3.89 M | - | 9.42 M | 5.54 M | 1.78 M | - | 3.54 M | 1.69 M | 127 K | - | 159 K | 105 K | 52.2 K | - | 73.4 K | 37.7 K | 313 | - | - | - | - |
Accounts Payables |
25.8 M | 16.7 M | 41.7 M | 24.7 M | 19.9 M | 16.7 M | 17.3 M | 14 M | - | 18.4 M | 15.1 M | 5.83 M | 8.34 M | 15 M | 12.1 M | 12.1 M | 12.1 M | 12.1 M | 26.6 M | 26.6 M | 26.6 M | 26.6 M | 6.95 M | 6.95 M | 6.95 M | 6.95 M | 18.9 M | 18.9 M | 18.9 M | 18.9 M | 7.52 M | 7.52 M | 7.52 M | 7.52 M | 7.64 M | 7.64 M | 7.64 M | 7.64 M | 7.12 M | 7.12 M | 7.12 M | 7.12 M | 3.55 M | 3.55 M | 3.55 M | 3.55 M | 1.02 M | 1.02 M | 1.02 M | 1.02 M | 340 K | - | - | - |
Accounts Receivables |
24.5 M | 22.7 M | 21.2 M | 14.6 M | 20.4 M | 21.5 M | 16.6 M | 12.7 M | - | 14.7 M | 15.9 M | 13.4 M | 11.9 M | 13.1 M | 15.9 M | 15.9 M | 15.9 M | 15.9 M | 18 M | 18 M | 18 M | 18 M | 12.7 M | 12.7 M | 12.7 M | 12.7 M | 13.9 M | 13.9 M | 13.9 M | 13.9 M | 18.5 M | 18.5 M | 18.5 M | 18.5 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M | 7.96 M | 7.96 M | 7.96 M | 7.96 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
43 M | 42.3 M | 40.9 M | 20.8 M | 18.8 M | 6.71 M | 4.52 M | 7.3 M | - | 6.52 M | 7.31 M | 6.62 M | 7.41 M | 7.18 M | 7.61 M | 7.61 M | 7.61 M | 7.61 M | 6.08 M | 6.08 M | 6.08 M | 6.08 M | 5.62 M | 5.62 M | 5.62 M | 5.62 M | 5.35 M | 5.35 M | 5.35 M | 5.35 M | 2.83 M | 2.83 M | 2.83 M | 2.83 M | 2.54 M | 2.54 M | 2.54 M | 2.54 M | 801 K | 801 K | 801 K | 801 K | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency